Literature DB >> 15701062

Relationship between control and the intermediate term outcome of anorexia nervosa in Hong Kong.

Sing Lee1, Y Y Lydia Chan, Kathleen Kwok, L K George Hsu.   

Abstract

OBJECTIVE: To examine the relationship between control and the intermediate term outcome of Chinese patients with anorexia nervosa.
METHOD: 88 patients who fulfilled the DSM-III-R criteria for typical (fat phobic, n=63) and atypical (non-fat phobic, n=25) anorexia nervosa were contacted 9 years after the onset of illness. They completed the Morgan-Russell Outcome Assessment Schedule, Shapiro Control Inventory, and Eating Disorder Inventory-I.
RESULTS: 62.2%, 32.4% and 5.4% of patients had good, intermediate, and poor outcome. Outcome was positively correlated with the overall general and specific sense of control, positive sense of control, and negatively with negative sense of control. Patients with good outcome exhibited the least negative modes of control and had the least desire for control. Typical and atypical patients showed similar but not identical control profiles.
CONCLUSION: Healthier control was associated with better outcome of anorexia nervosa but their causal relationship was far from clear because of the cross-sectional nature of the present study. The Shapiro Control Inventory is a potentially useful instrument for studying control in eating disorders.

Entities:  

Mesh:

Year:  2005        PMID: 15701062     DOI: 10.1080/j.1440-1614.2005.01535.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  2 in total

1.  Blind versus open weighing from an eating disorder patient perspective.

Authors:  Franzisca V Froreich; Sarah E Ratcliffe; Lenny R Vartanian
Journal:  J Eat Disord       Date:  2020-08-17

2.  Dimensions of control and their relation to disordered eating behaviours and obsessive-compulsive symptoms.

Authors:  Franzisca V Froreich; Lenny R Vartanian; Jessica R Grisham; Stephen W Touyz
Journal:  J Eat Disord       Date:  2016-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.